Abezino Tablet

About Abezino 200 mg Tablet

Abezino is a tablet medicine from Healthcare Pharmaceuticals Ltd. that contains abemaciclib 200 mg. It belongs to a group of medicines called protein kinase inhibitors and is prescribed as part of treatment for certain types of breast cancer.

There are 6 brands of Abemaciclib listed in Bangladesh. 3 of them have a lower unit price than Abezino. The lowest listed price is Abeza 150 mg Tablet at ৳ 950.00 per unit.

What is Abezino 200 mg Tablet?

Abezino is made by Healthcare Pharmaceuticals Ltd. and contains abemaciclib 200 mg in tablet form. Abemaciclib works as a protein kinase inhibitor: it blocks certain proteins that help cancer cells divide and grow. Doctors use it in adults as part of a treatment plan for some hormone receptor-positive, HER2-negative breast cancers, usually together with hormonal therapy. Because it is a specialist cancer medicine, it is started and followed by a qualified doctor. The doctor decides whether it suits a particular patient and how the treatment should be managed.

Uses of Abezino

Abezino is used in adults for certain breast cancers that are hormone receptor-positive and HER2-negative. It is given together with hormonal therapy such as tamoxifen or an aromatase inhibitor, and in some situations as a single treatment. It is meant for patients whose doctor has confirmed the cancer type and stage and decided that this medicine is appropriate. It is not a general-purpose medicine and should only be used under cancer specialist care.

How to use Abezino

Abezino tablets are swallowed whole with water, with or without food, as directed by the doctor. The doctor sets the dose, the timing and how long the course lasts, and may change these based on how the patient responds and tolerates the medicine. Do not adjust the schedule yourself. If a dose is missed or vomiting occurs, ask the doctor or pharmacist what to do rather than guessing. Keep the tablets in their pack and store them as instructed.

Side effects of Abezino

Common side effects of abemaciclib include diarrhea, nausea, vomiting, stomach pain, tiredness, headache, hair loss, decreased appetite and infections. Blood-related effects such as low white cell counts, low red cell counts and low platelet counts can also occur. Some people develop serious problems, including severe diarrhea with dehydration, low white cell counts, and lung inflammation. The doctor monitors for these. Tell the doctor promptly about loose stools, fever, breathing trouble or unusual bleeding.

Safety and precautions

Abezino can harm an unborn baby, so pregnant women should not take it. Women who could become pregnant should use effective contraception during treatment and for a period after the last dose as advised by the doctor. Breastfeeding should be discussed with the doctor. People with diarrhea, low blood counts or lung problems need close medical monitoring. Tell the doctor about all other medicines, since some can interact with abemaciclib. Anyone with liver or kidney problems, or who is unsure whether this medicine suits them, should ask the doctor first.

Frequently asked questions

What is the price of Abezino?

The listed price is ৳ 1150.00. Prices can change, so check the current figure on the site or at the pharmacy. Your doctor or pharmacist can also tell you about availability and any cost questions.

Who should avoid Abezino or ask the doctor first?

Pregnant women should not take it, and women who could become pregnant need effective contraception as the doctor advises. People with liver or kidney problems, ongoing diarrhea, low blood counts, lung problems, or those taking other medicines should speak to the doctor before starting.

What is Abezino used for and what kind of medicine is it?

Abezino is a protein kinase inhibitor. It is used in adults for certain hormone receptor-positive, HER2-negative breast cancers, often together with hormonal therapy. The doctor confirms whether it fits the patient's cancer type and treatment plan.

What do the tablet form and 200 mg strength mean?

Abezino comes as a tablet, so it is swallowed. The 200 mg strength tells you how much abemaciclib each tablet contains. How much and how often to take it is decided only by the doctor, based on the treatment plan.

Also available as

150 mg (Tablet)

Indications

Abezino is a kinase inhibitor indicated:
  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
  • ... Read more
Abezino is a kinase inhibitor indicated:
  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
  • in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
  • in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
  • as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.

Pharmacology

Abemaciclib is an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4 and CDK6). These kinases are activated upon binding to D-cyclins. In estrogen receptor-positive (ER+) breast cancer cell lines, cyclin D1 and CDK4/6 promote phosphorylation of the retinoblastoma protein (Rb), cell cycle progression, and cell proliferation. In vitro, continuous exposure to abemaciclib inhibited Rb phosphorylation and blocked progression from G1 into S phase of the cell cycle, resulting in senescence and apoptosis. In breast cancer xenograft models, abemaciclib dosed daily without interruption as a single agent or in combination with antiestrogens resulted in reduction of tumor size.

Dosage & Administration

Abemaciclib tablets are taken orally with or without food.
  • Recommended starting dose in combination with fulvestrant, tamoxifen, or an aromatase inhibitor: 150 mg twice daily.
  • Recommended starting dose as monotherapy: 200 mg twice daily.
  • Dosing interruption and/or dose reductions may be required based on individual safety and tolerability.

Interaction

CYP3A Inhibitors: Avoid concomitant use of ketoconazole. Reduce the Abezino dose with concomitant use of other strong and moderate CYP3A inhibitors.
CYP3A Inducers: Avoid concomitant use of strong and moderate CYP3A inducers.

Side Effects

Most common adverse reactions (incidence ≥20%) were diarrhea, neutropenia, nausea, abdominal pain, infections, fatigue, anemia, leukopenia, decreased appetite, vomiting, headache, alopecia, and thrombocytopenia.

Pregnancy & Lactation

Based on findings from animal studies and the mechanism of action, Abemaciclib can cause fetal harm when administered to a pregnant woman. In animal reproduction studies, administration of abemaciclib to pregnant rats during the period of organogenesis caused teratogenicity and decreased fetal weight at maternal exposures that were similar to the human clinical exposure based on area under the curve (AUC) at the maximum recommended human dose. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with Abemaciclib and for 3 weeks after the last dose.

Precautions & Warnings

Diarrhea: Abezino can cause severe cases of diarrhea, associated with dehydration and infection. Instruct patients at the first sign of loose stools to initiate antidiarrheal therapy, increase oral fluids, and notify their healthcare provider.

Neutropenia: Monitor complete blood counts prior to the start of Abezino therapy, every 2 weeks for the first 2 months, monthly for the next 2 months, and as clinically indicated.

Interstitial Lung Disease (ILD)/Pneumonitis: Severe and fatal cases of ILD/pneumonitis have been reported. Monitor for clinical symptoms or radiological changes indicative of ILD/pneumonitis. Permanently discontinue Abezino in all patients with Grade 3 or 4 ILD or pneumonitis.

Hepatotoxicity: Increases in serum transaminase levels have been observed. Perform liver function tests (LFTs) before initiating treatment with Abezino. Monitor LFTs every two weeks for the first two months, monthly for the next 2 months, and as clinically indicated.

Venous Thromboembolism: Monitor patients for signs and symptoms of thrombosis and pulmonary embolism and treat as medically appropriate.

Embryo-Fetal Toxicity: Can cause fetal harm. Advise patients of potential

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Abemaciclib

Other brands with the same generic name, cheapest first.

Abeclib Tablet

150 mg

Abemaciclib

Eskayef Pharmaceuticals Ltd.

৳ 931 ৳ 950.00 2% off per unit

Abeza Tablet

150 mg

Abemaciclib

Beacon Pharmaceuticals PLC

৳ 931 ৳ 950.00 2% off per unit

Abezino Tablet

150 mg

Abemaciclib

Healthcare Pharmaceuticals Ltd.

৳ 931 ৳ 950.00 2% off per unit

Abeclib Tablet

200 mg

Abemaciclib

Eskayef Pharmaceuticals Ltd.

৳ 1127 ৳ 1150.00 2% off per unit

Abeza Tablet

200 mg

Abemaciclib

Beacon Pharmaceuticals PLC

৳ 1127 ৳ 1150.00 2% off per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.